Inhibitory effects of SR141716A on G-protein activation in rat brain
- 28 February 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 414 (2-3) , 135-143
- https://doi.org/10.1016/s0014-2999(01)00784-1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestineBritish Journal of Pharmacology, 2000
- Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat BrainJournal of Neurochemistry, 1999
- Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPγS Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP AffinityPublished by Elsevier ,1998
- Appetite suppression and weight loss after the cannabinoid antagonist SR 141716Life Sciences, 1998
- Cannabinoid modulation of intestinal propulsion in miceEuropean Journal of Pharmacology, 1998
- A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1Journal of Biological Chemistry, 1997
- Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1Biochemical Journal, 1995
- Effects of anandamide on cannabinoid receptors in rat brain membranesBiochemical Pharmacology, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964